

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.87718484 |
| 2 | urate metabolic process (GO:0046415) | 9.51081622 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.72964860 |
| 4 | drug transport (GO:0015893) | 8.30534100 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 8.10830812 |
| 6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.86037110 |
| 7 | drug catabolic process (GO:0042737) | 7.48892285 |
| 8 | phosphate ion transport (GO:0006817) | 7.27868177 |
| 9 | lipoprotein transport (GO:0042953) | 7.21529813 |
| 10 | exogenous drug catabolic process (GO:0042738) | 6.96491017 |
| 11 | organic cation transport (GO:0015695) | 6.88722060 |
| 12 | lysine catabolic process (GO:0006554) | 6.86492648 |
| 13 | lysine metabolic process (GO:0006553) | 6.86492648 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 6.86410312 |
| 15 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.68727865 |
| 16 | phosphate ion transmembrane transport (GO:0035435) | 6.39346624 |
| 17 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.21671085 |
| 18 | quaternary ammonium group transport (GO:0015697) | 6.04275091 |
| 19 | cysteine metabolic process (GO:0006534) | 5.87164065 |
| 20 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.66332009 |
| 21 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.66332009 |
| 22 | endocrine process (GO:0050886) | 5.66332009 |
| 23 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.54588550 |
| 24 | modified amino acid transport (GO:0072337) | 5.46719571 |
| 25 | homocysteine metabolic process (GO:0050667) | 5.46649675 |
| 26 | glyoxylate metabolic process (GO:0046487) | 5.42685348 |
| 27 | hormone catabolic process (GO:0042447) | 5.32591637 |
| 28 | glutathione biosynthetic process (GO:0006750) | 5.12431335 |
| 29 | renal absorption (GO:0070293) | 5.08802781 |
| 30 | regulation of bile acid biosynthetic process (GO:0070857) | 5.07222138 |
| 31 | excretion (GO:0007588) | 5.06736516 |
| 32 | regulation of systemic arterial blood pressure (GO:0003073) | 5.06477876 |
| 33 | bile acid and bile salt transport (GO:0015721) | 5.00878141 |
| 34 | virion attachment to host cell (GO:0019062) | 4.92586262 |
| 35 | adhesion of symbiont to host cell (GO:0044650) | 4.92586262 |
| 36 | regulation of cGMP biosynthetic process (GO:0030826) | 4.91102634 |
| 37 | regulation of cellular extravasation (GO:0002691) | 4.89969511 |
| 38 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.87406484 |
| 39 | vitamin D metabolic process (GO:0042359) | 4.84123328 |
| 40 | short-chain fatty acid metabolic process (GO:0046459) | 4.81435284 |
| 41 | response to mercury ion (GO:0046689) | 4.78318442 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.76608627 |
| 43 | tricarboxylic acid metabolic process (GO:0072350) | 4.73047858 |
| 44 | amino-acid betaine transport (GO:0015838) | 4.71569017 |
| 45 | carnitine transport (GO:0015879) | 4.71569017 |
| 46 | renal system process involved in regulation of blood volume (GO:0001977) | 4.64053420 |
| 47 | sulfur compound transport (GO:0072348) | 4.60915790 |
| 48 | diacylglycerol metabolic process (GO:0046339) | 4.59903677 |
| 49 | intestinal absorption (GO:0050892) | 4.56989090 |
| 50 | urea cycle (GO:0000050) | 4.52852837 |
| 51 | phosphate ion homeostasis (GO:0055062) | 4.51459594 |
| 52 | trivalent inorganic anion homeostasis (GO:0072506) | 4.51459594 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.51047474 |
| 54 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.48151260 |
| 55 | toxin transport (GO:1901998) | 4.41381085 |
| 56 | aspartate family amino acid catabolic process (GO:0009068) | 4.40100352 |
| 57 | peptide hormone processing (GO:0016486) | 4.39759268 |
| 58 | sulfur amino acid catabolic process (GO:0000098) | 4.37157672 |
| 59 | regulation of vitamin metabolic process (GO:0030656) | 4.36493007 |
| 60 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.35730350 |
| 61 | digestion (GO:0007586) | 4.32406488 |
| 62 | urea metabolic process (GO:0019627) | 4.30487862 |
| 63 | fructose metabolic process (GO:0006000) | 4.22977221 |
| 64 | adhesion of symbiont to host (GO:0044406) | 4.17981566 |
| 65 | glycolipid catabolic process (GO:0019377) | 4.15968601 |
| 66 | fatty acid beta-oxidation (GO:0006635) | 4.13930017 |
| 67 | glycosphingolipid catabolic process (GO:0046479) | 4.13664816 |
| 68 | peptide biosynthetic process (GO:0043043) | 4.11283916 |
| 69 | vitamin A metabolic process (GO:0006776) | 4.09125210 |
| 70 | regulation of cGMP metabolic process (GO:0030823) | 4.08234739 |
| 71 | branched-chain amino acid metabolic process (GO:0009081) | 4.07509234 |
| 72 | sulfate transmembrane transport (GO:1902358) | 4.04561321 |
| 73 | vitamin transport (GO:0051180) | 4.01786405 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 4.00432851 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 3.99221709 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 3.97103049 |
| 77 | nitrogen cycle metabolic process (GO:0071941) | 3.96087427 |
| 78 | flavonoid metabolic process (GO:0009812) | 3.95241280 |
| 79 | angiotensin maturation (GO:0002003) | 3.89261831 |
| 80 | oligosaccharide catabolic process (GO:0009313) | 3.87589137 |
| 81 | peptide catabolic process (GO:0043171) | 3.87544857 |
| 82 | metanephric tubule development (GO:0072170) | 3.87203729 |
| 83 | metanephric nephron tubule development (GO:0072234) | 3.87203729 |
| 84 | serine family amino acid catabolic process (GO:0009071) | 3.85962097 |
| 85 | drug metabolic process (GO:0017144) | 3.85197284 |
| 86 | L-phenylalanine metabolic process (GO:0006558) | 3.84178078 |
| 87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.84178078 |
| 88 | serine family amino acid metabolic process (GO:0009069) | 3.84114607 |
| 89 | NADH metabolic process (GO:0006734) | 3.84055391 |
| 90 | actin filament depolymerization (GO:0030042) | 3.82828168 |
| 91 | fatty acid oxidation (GO:0019395) | 3.80395608 |
| 92 | cellular response to nitric oxide (GO:0071732) | 3.78385966 |
| 93 | valine metabolic process (GO:0006573) | 3.78167548 |
| 94 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.75398034 |
| 95 | antibacterial humoral response (GO:0019731) | 3.74398386 |
| 96 | drinking behavior (GO:0042756) | 3.73713047 |
| 97 | lipid oxidation (GO:0034440) | 3.72535182 |
| 98 | glycoside metabolic process (GO:0016137) | 3.72209927 |
| 99 | glutathione metabolic process (GO:0006749) | 3.71549788 |
| 100 | carnitine metabolic process (GO:0009437) | 3.71428805 |
| 101 | L-phenylalanine catabolic process (GO:0006559) | 3.71166745 |
| 102 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.71166745 |
| 103 | positive regulation of pseudopodium assembly (GO:0031274) | 3.70676522 |
| 104 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.69369482 |
| 105 | alkaloid metabolic process (GO:0009820) | 3.68971629 |
| 106 | cellular modified amino acid catabolic process (GO:0042219) | 3.68406502 |
| 107 | protein-lipid complex assembly (GO:0065005) | 3.64660152 |
| 108 | fat-soluble vitamin metabolic process (GO:0006775) | 3.64651373 |
| 109 | antimicrobial humoral response (GO:0019730) | 3.63439699 |
| 110 | aromatic amino acid family catabolic process (GO:0009074) | 3.63318427 |
| 111 | regulation of cholesterol homeostasis (GO:2000188) | 3.60559245 |
| 112 | lipoprotein metabolic process (GO:0042157) | 3.60155106 |
| 113 | neurotransmitter biosynthetic process (GO:0042136) | 3.59397945 |
| 114 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.57742346 |
| 115 | cGMP biosynthetic process (GO:0006182) | 3.57547994 |
| 116 | metanephric nephron epithelium development (GO:0072243) | 3.53784825 |
| 117 | proline metabolic process (GO:0006560) | 3.53482441 |
| 118 | tryptophan catabolic process (GO:0006569) | 3.52194581 |
| 119 | indole-containing compound catabolic process (GO:0042436) | 3.52194581 |
| 120 | indolalkylamine catabolic process (GO:0046218) | 3.52194581 |
| 121 | transepithelial transport (GO:0070633) | 3.47441549 |
| 122 | fatty acid catabolic process (GO:0009062) | 3.46677393 |
| 123 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46649408 |
| 124 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.46462171 |
| 125 | cGMP-mediated signaling (GO:0019934) | 3.44712850 |
| 126 | glutathione derivative metabolic process (GO:1901685) | 3.40146431 |
| 127 | glutathione derivative biosynthetic process (GO:1901687) | 3.40146431 |
| 128 | ketone body metabolic process (GO:1902224) | 3.39832382 |
| 129 | glycosylceramide metabolic process (GO:0006677) | 3.38515749 |
| 130 | tryptophan metabolic process (GO:0006568) | 3.38203895 |
| 131 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.36670060 |
| 132 | response to phenylpropanoid (GO:0080184) | 3.36583080 |
| 133 | response to nitric oxide (GO:0071731) | 3.34181061 |
| 134 | ceramide catabolic process (GO:0046514) | 3.33506281 |
| 135 | branched-chain amino acid catabolic process (GO:0009083) | 3.33031425 |
| 136 | amino acid transmembrane transport (GO:0003333) | 3.32140882 |
| 137 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.32102691 |
| 138 | uronic acid metabolic process (GO:0006063) | 3.31986259 |
| 139 | glucuronate metabolic process (GO:0019585) | 3.31986259 |
| 140 | regulation of pseudopodium assembly (GO:0031272) | 3.31668366 |
| 141 | bile acid metabolic process (GO:0008206) | 3.31334302 |
| 142 | cellular response to reactive nitrogen species (GO:1902170) | 3.30021079 |
| 143 | positive regulation of lipid catabolic process (GO:0050996) | 3.30003943 |
| 144 | vitamin biosynthetic process (GO:0009110) | 3.29869548 |
| 145 | phospholipid efflux (GO:0033700) | 3.29823911 |
| 146 | sphingomyelin metabolic process (GO:0006684) | 3.29399543 |
| 147 | digestive system process (GO:0022600) | 3.29003240 |
| 148 | acetyl-CoA metabolic process (GO:0006084) | 3.28593961 |
| 149 | glycerol metabolic process (GO:0006071) | 3.27679575 |
| 150 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.27493762 |
| 151 | sodium ion transport (GO:0006814) | 3.27470534 |
| 152 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.26829023 |
| 153 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.26829023 |
| 154 | transcytosis (GO:0045056) | 3.26726484 |
| 155 | sulfate transport (GO:0008272) | 3.26492058 |
| 156 | vitamin transmembrane transport (GO:0035461) | 3.25788817 |
| 157 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.25711063 |
| 158 | polyol transport (GO:0015791) | 3.22632240 |
| 159 | arginine metabolic process (GO:0006525) | 3.20128546 |
| 160 | response to growth hormone (GO:0060416) | 3.19019343 |
| 161 | sphingolipid catabolic process (GO:0030149) | 3.18796733 |
| 162 | metanephric epithelium development (GO:0072207) | 3.17988992 |
| 163 | cobalamin metabolic process (GO:0009235) | 3.16895464 |
| 164 | beta-amyloid metabolic process (GO:0050435) | 3.16298177 |
| 165 | cellular response to vitamin D (GO:0071305) | 3.16250614 |
| 166 | regulation of cholesterol esterification (GO:0010872) | 3.15451194 |
| 167 | cellular glucuronidation (GO:0052695) | 3.14281463 |
| 168 | sulfur amino acid metabolic process (GO:0000096) | 3.13985630 |
| 169 | mRNA modification (GO:0016556) | 3.13693100 |
| 170 | cytidine metabolic process (GO:0046087) | 3.10113712 |
| 171 | cytidine catabolic process (GO:0006216) | 3.10113712 |
| 172 | cytidine deamination (GO:0009972) | 3.10113712 |
| 173 | positive regulation of cGMP metabolic process (GO:0030825) | 3.10075046 |
| 174 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.09424905 |
| 175 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.09424905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.90672477 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.20686080 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.14790162 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00755044 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63577052 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42056948 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.36625982 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20669313 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.04806560 |
| 10 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.95983497 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.89101016 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.83901017 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.74626380 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.73517097 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.70766709 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58383074 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.56248694 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.36370361 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.32052088 |
| 20 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.25684542 |
| 21 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.23825833 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20395443 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.19754925 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16104567 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14035360 |
| 26 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.07998799 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94837011 |
| 28 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.86746516 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.81214847 |
| 30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.79121910 |
| 31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.74280174 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74202045 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.72726120 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72347882 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.69689859 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69526670 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66743511 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.64754057 |
| 39 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63889236 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63213142 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62879015 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.62205794 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54667358 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.48328846 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47138510 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46751049 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.38886621 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38847564 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.37984804 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.37883605 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36494140 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33613652 |
| 53 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32559409 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31372604 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.28872731 |
| 56 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24135919 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22455971 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21179256 |
| 59 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20798266 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20796262 |
| 61 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18764675 |
| 62 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18047785 |
| 63 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16438670 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16213183 |
| 65 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.14620756 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11354408 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10223500 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10003783 |
| 69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09998320 |
| 70 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09840159 |
| 71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09505803 |
| 72 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.07670877 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06296936 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05364990 |
| 75 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04241366 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03268111 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02763784 |
| 78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01028606 |
| 79 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.00955377 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00204428 |
| 81 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00090381 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99564967 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98943547 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.97670212 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96376269 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96312894 |
| 87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.95697430 |
| 88 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95361177 |
| 89 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93327801 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93068611 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92583345 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.90897892 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89801138 |
| 94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89633880 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89133674 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88264506 |
| 97 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88252233 |
| 98 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88236864 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86092908 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85584987 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85521597 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84830834 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83965791 |
| 104 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83661960 |
| 105 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83295264 |
| 106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82862697 |
| 107 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82818161 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82592350 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82569745 |
| 110 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82457516 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82197221 |
| 112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81799028 |
| 113 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.80060128 |
| 114 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79749836 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79621092 |
| 116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78177884 |
| 117 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78122513 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77926117 |
| 119 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77612369 |
| 120 | * CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.77377720 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77286039 |
| 122 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76937721 |
| 123 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76053081 |
| 124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75654734 |
| 125 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75072461 |
| 126 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.75030347 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.74045588 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73460889 |
| 129 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.72661100 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.70963001 |
| 131 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.70784636 |
| 132 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.70557880 |
| 133 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.70557880 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69337003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.82725975 |
| 2 | MP0004043_abnormal_pH_regulation | 4.95942186 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.15785308 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 4.05576430 |
| 5 | MP0005332_abnormal_amino_acid | 3.91492381 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.70406191 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.58334653 |
| 8 | MP0005377_hearing/vestibular/ear_phenot | 3.50719561 |
| 9 | MP0003878_abnormal_ear_physiology | 3.50719561 |
| 10 | MP0005365_abnormal_bile_salt | 3.38241286 |
| 11 | MP0009643_abnormal_urine_homeostasis | 3.38073190 |
| 12 | MP0009840_abnormal_foam_cell | 3.33138629 |
| 13 | MP0001765_abnormal_ion_homeostasis | 3.19858327 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 3.01863051 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.95337311 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.84833543 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.78023960 |
| 18 | MP0003252_abnormal_bile_duct | 2.67693144 |
| 19 | MP0005636_abnormal_mineral_homeostasis | 2.63436937 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.59814845 |
| 21 | MP0003195_calcinosis | 2.44343670 |
| 22 | MP0001756_abnormal_urination | 2.41294148 |
| 23 | MP0002136_abnormal_kidney_physiology | 2.34758243 |
| 24 | MP0005409_darkened_coat_color | 2.18244473 |
| 25 | MP0000538_abnormal_urinary_bladder | 2.08544467 |
| 26 | MP0004147_increased_porphyrin_level | 1.90262919 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.72244189 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.68182164 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.64192538 |
| 30 | MP0001958_emphysema | 1.62414364 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.60569316 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.51578032 |
| 33 | MP0003866_abnormal_defecation | 1.43867790 |
| 34 | MP0001188_hyperpigmentation | 1.43598963 |
| 35 | MP0005451_abnormal_body_composition | 1.42314693 |
| 36 | MP0002822_catalepsy | 1.40473901 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.39446817 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25508235 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.23992855 |
| 40 | MP0004885_abnormal_endolymph | 1.23674607 |
| 41 | MP0002796_impaired_skin_barrier | 1.23535480 |
| 42 | MP0001663_abnormal_digestive_system | 1.23183230 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.21846053 |
| 44 | MP0000462_abnormal_digestive_system | 1.15694553 |
| 45 | MP0003718_maternal_effect | 1.14093473 |
| 46 | MP0005381_digestive/alimentary_phenotyp | 1.10404897 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.08962631 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.08713027 |
| 49 | MP0001664_abnormal_digestion | 1.07971369 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.06414128 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.06135971 |
| 52 | MP0001873_stomach_inflammation | 1.06089996 |
| 53 | MP0005448_abnormal_energy_balance | 1.02320149 |
| 54 | MP0003186_abnormal_redox_activity | 1.02206002 |
| 55 | MP0003283_abnormal_digestive_organ | 1.02100112 |
| 56 | MP0004270_analgesia | 1.01394546 |
| 57 | MP0003868_abnormal_feces_composition | 0.98544942 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 0.96634106 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.94949222 |
| 60 | MP0002971_abnormal_brown_adipose | 0.94067123 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 0.92548107 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 0.92474347 |
| 63 | MP0005666_abnormal_adipose_tissue | 0.91404013 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.90396041 |
| 65 | MP0004858_abnormal_nervous_system | 0.89388263 |
| 66 | MP0002396_abnormal_hematopoietic_system | 0.88321803 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.88157243 |
| 68 | MP0005501_abnormal_skin_physiology | 0.86958589 |
| 69 | MP0000477_abnormal_intestine_morphology | 0.85753946 |
| 70 | MP0001845_abnormal_inflammatory_respons | 0.84577735 |
| 71 | MP0000609_abnormal_liver_physiology | 0.84569649 |
| 72 | MP0006054_spinal_hemorrhage | 0.81241236 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.80216412 |
| 74 | MP0009115_abnormal_fat_cell | 0.78827932 |
| 75 | MP0002135_abnormal_kidney_morphology | 0.77677667 |
| 76 | MP0009785_altered_susceptibility_to | 0.77019739 |
| 77 | MP0002896_abnormal_bone_mineralization | 0.74863234 |
| 78 | MP0003724_increased_susceptibility_to | 0.74785048 |
| 79 | MP0001764_abnormal_homeostasis | 0.70469348 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.70256984 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.69437848 |
| 82 | MP0000537_abnormal_urethra_morphology | 0.69363225 |
| 83 | MP0005535_abnormal_body_temperature | 0.67127126 |
| 84 | MP0000490_abnormal_crypts_of | 0.66956495 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.65667939 |
| 86 | MP0003879_abnormal_hair_cell | 0.64076001 |
| 87 | MP0005310_abnormal_salivary_gland | 0.62678673 |
| 88 | MP0002168_other_aberrant_phenotype | 0.60869507 |
| 89 | MP0005670_abnormal_white_adipose | 0.59663580 |
| 90 | MP0000249_abnormal_blood_vessel | 0.58059624 |
| 91 | MP0005025_abnormal_response_to | 0.57716516 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 0.56766101 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.54957157 |
| 94 | MP0006082_CNS_inflammation | 0.54630381 |
| 95 | MP0003941_abnormal_skin_development | 0.54547868 |
| 96 | MP0003303_peritoneal_inflammation | 0.53368963 |
| 97 | MP0005408_hypopigmentation | 0.53056979 |
| 98 | MP0001835_abnormal_antigen_presentation | 0.52886025 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.52566356 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.52361383 |
| 101 | MP0004947_skin_inflammation | 0.52041531 |
| 102 | MP0004484_altered_response_of | 0.50039576 |
| 103 | MP0000747_muscle_weakness | 0.49833959 |
| 104 | MP0002006_tumorigenesis | 0.49572361 |
| 105 | MP0001661_extended_life_span | 0.49400366 |
| 106 | MP0002928_abnormal_bile_duct | 0.48933466 |
| 107 | MP0010352_gastrointestinal_tract_polyps | 0.48683305 |
| 108 | MP0006138_congestive_heart_failure | 0.48319992 |
| 109 | MP0005334_abnormal_fat_pad | 0.47554749 |
| 110 | MP0002009_preneoplasia | 0.47368162 |
| 111 | MP0008469_abnormal_protein_level | 0.47035176 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.46779982 |
| 113 | MP0003436_decreased_susceptibility_to | 0.46769701 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.46760571 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.45861631 |
| 116 | MP0005166_decreased_susceptibility_to | 0.45118167 |
| 117 | MP0001849_ear_inflammation | 0.44299961 |
| 118 | MP0002148_abnormal_hypersensitivity_rea | 0.44055531 |
| 119 | MP0000598_abnormal_liver_morphology | 0.43659948 |
| 120 | MP0001485_abnormal_pinna_reflex | 0.43105934 |
| 121 | MP0000604_amyloidosis | 0.43095320 |
| 122 | MP0000566_synostosis | 0.42528808 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.42146386 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.41961668 |
| 125 | MP0000678_abnormal_parathyroid_gland | 0.41760117 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.40760341 |
| 127 | MP0003315_abnormal_perineum_morphology | 0.39898432 |
| 128 | MP0009764_decreased_sensitivity_to | 0.39897955 |
| 129 | MP0005165_increased_susceptibility_to | 0.39533130 |
| 130 | MP0003329_amyloid_beta_deposits | 0.39072412 |
| 131 | MP0006035_abnormal_mitochondrial_morpho | 0.38596946 |
| 132 | MP0005395_other_phenotype | 0.38570731 |
| 133 | MP0003953_abnormal_hormone_level | 0.37620357 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.37328149 |
| 135 | MP0000377_abnormal_hair_follicle | 0.37210386 |
| 136 | MP0008872_abnormal_physiological_respon | 0.36657502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 7.08404160 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 6.76479490 |
| 3 | Increased circulating renin level (HP:0000848) | 6.71735024 |
| 4 | Gout (HP:0001997) | 6.21524289 |
| 5 | Hypomagnesemia (HP:0002917) | 6.21222198 |
| 6 | Hypokalemic alkalosis (HP:0001949) | 6.15976127 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 6.05842683 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.76437764 |
| 9 | Abnormality of magnesium homeostasis (HP:0004921) | 5.54909616 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.45744019 |
| 11 | Polyuria (HP:0000103) | 5.39033908 |
| 12 | Abnormal urine output (HP:0012590) | 5.16388612 |
| 13 | Proximal tubulopathy (HP:0000114) | 5.10394565 |
| 14 | Abnormality of renal excretion (HP:0011036) | 5.01305255 |
| 15 | Hyperglycinuria (HP:0003108) | 5.00801601 |
| 16 | Increased purine levels (HP:0004368) | 4.71999231 |
| 17 | Hyperuricemia (HP:0002149) | 4.71999231 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 4.59858258 |
| 19 | Acanthocytosis (HP:0001927) | 4.59086510 |
| 20 | Tetany (HP:0001281) | 4.54622120 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 4.50564226 |
| 22 | Alkalosis (HP:0001948) | 4.40419551 |
| 23 | Hyperaldosteronism (HP:0000859) | 4.35020282 |
| 24 | Abnormal drinking behavior (HP:0030082) | 4.19026006 |
| 25 | Polydipsia (HP:0001959) | 4.19026006 |
| 26 | Abnormality of vitamin metabolism (HP:0100508) | 4.02517135 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.99992200 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99992200 |
| 29 | Renal salt wasting (HP:0000127) | 3.90778748 |
| 30 | Abnormality of proline metabolism (HP:0010907) | 3.76037560 |
| 31 | Hydroxyprolinuria (HP:0003080) | 3.76037560 |
| 32 | Generalized aminoaciduria (HP:0002909) | 3.73757255 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 3.71571455 |
| 34 | Hypercalciuria (HP:0002150) | 3.67458544 |
| 35 | Malnutrition (HP:0004395) | 3.58166019 |
| 36 | Glycosuria (HP:0003076) | 3.56486876 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 3.56486876 |
| 38 | Ketoacidosis (HP:0001993) | 3.44885923 |
| 39 | Hypokalemia (HP:0002900) | 3.37136770 |
| 40 | Wide cranial sutures (HP:0010537) | 3.36103846 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 3.31904980 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.26544379 |
| 43 | Ileus (HP:0002595) | 3.22890343 |
| 44 | Congenital sensorineural hearing impairment (HP:0008527) | 3.18388363 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.15694833 |
| 46 | Hyperphosphaturia (HP:0003109) | 3.10308475 |
| 47 | Nephrolithiasis (HP:0000787) | 3.08096742 |
| 48 | Renal tubular acidosis (HP:0001947) | 3.06918350 |
| 49 | Xanthomatosis (HP:0000991) | 3.03458835 |
| 50 | Delayed epiphyseal ossification (HP:0002663) | 3.01533978 |
| 51 | Megaloblastic anemia (HP:0001889) | 2.94646917 |
| 52 | Dehydration (HP:0001944) | 2.88735996 |
| 53 | Abnormal urine phosphate concentration (HP:0012599) | 2.88394672 |
| 54 | Ketosis (HP:0001946) | 2.86897386 |
| 55 | Steatorrhea (HP:0002570) | 2.84802414 |
| 56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.83916308 |
| 57 | Posterior subcapsular cataract (HP:0007787) | 2.82991991 |
| 58 | Abnormality of potassium homeostasis (HP:0011042) | 2.81247636 |
| 59 | Vacuolated lymphocytes (HP:0001922) | 2.76647774 |
| 60 | Hyperparathyroidism (HP:0000843) | 2.72841439 |
| 61 | Enlarged epiphyses (HP:0010580) | 2.69312428 |
| 62 | Hypolipoproteinemia (HP:0010981) | 2.67791593 |
| 63 | Hyperglycinemia (HP:0002154) | 2.64321363 |
| 64 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.60884046 |
| 65 | Villous atrophy (HP:0011473) | 2.60884046 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56660395 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.56660395 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.56350280 |
| 69 | Confusion (HP:0001289) | 2.55050939 |
| 70 | Vascular calcification (HP:0004934) | 2.54777422 |
| 71 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.53957336 |
| 72 | Hypophosphatemia (HP:0002148) | 2.52926668 |
| 73 | Widely patent fontanelles and sutures (HP:0004492) | 2.52759252 |
| 74 | Hyperammonemia (HP:0001987) | 2.50210285 |
| 75 | Focal segmental glomerulosclerosis (HP:0000097) | 2.46560839 |
| 76 | Nephrocalcinosis (HP:0000121) | 2.44380658 |
| 77 | Hemorrhage of the eye (HP:0011885) | 2.40621097 |
| 78 | Hypotension (HP:0002615) | 2.40546388 |
| 79 | Rickets (HP:0002748) | 2.35695694 |
| 80 | Abnormal tarsal ossification (HP:0008369) | 2.33478057 |
| 81 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.30574661 |
| 82 | Metabolic acidosis (HP:0001942) | 2.28945368 |
| 83 | Thin bony cortex (HP:0002753) | 2.26254216 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.26018193 |
| 85 | Hyponatremia (HP:0002902) | 2.22162947 |
| 86 | Chronic diarrhea (HP:0002028) | 2.22053646 |
| 87 | Metaphyseal cupping (HP:0003021) | 2.21829175 |
| 88 | Fat malabsorption (HP:0002630) | 2.17144660 |
| 89 | Delayed CNS myelination (HP:0002188) | 2.16375063 |
| 90 | Vomiting (HP:0002013) | 2.16022836 |
| 91 | Abnormality of sodium homeostasis (HP:0010931) | 2.14862453 |
| 92 | Protuberant abdomen (HP:0001538) | 2.13798701 |
| 93 | Abnormality of vitamin B metabolism (HP:0004340) | 2.12393237 |
| 94 | Epidermoid cyst (HP:0200040) | 2.10454892 |
| 95 | Cerebral palsy (HP:0100021) | 2.08186139 |
| 96 | Adrenal overactivity (HP:0002717) | 2.07223014 |
| 97 | Decreased circulating renin level (HP:0003351) | 2.07087373 |
| 98 | Abnormal glucose tolerance (HP:0001952) | 2.05286131 |
| 99 | Intrahepatic cholestasis (HP:0001406) | 2.05191504 |
| 100 | Subcapsular cataract (HP:0000523) | 2.05180180 |
| 101 | Lethargy (HP:0001254) | 2.04667482 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.04159583 |
| 103 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.03296658 |
| 104 | Nausea (HP:0002018) | 2.01121277 |
| 105 | Poikilocytosis (HP:0004447) | 2.00939225 |
| 106 | Hyperphosphatemia (HP:0002905) | 2.00632375 |
| 107 | Flat acetabular roof (HP:0003180) | 2.00349039 |
| 108 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98631437 |
| 109 | Pancreatitis (HP:0001733) | 1.92830487 |
| 110 | Gastrointestinal dysmotility (HP:0002579) | 1.90629358 |
| 111 | Abnormality of renal resorption (HP:0011038) | 1.88804300 |
| 112 | Gingivitis (HP:0000230) | 1.88746752 |
| 113 | Growth hormone excess (HP:0000845) | 1.88165263 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 1.86878557 |
| 115 | Methylmalonic aciduria (HP:0012120) | 1.86780191 |
| 116 | Abnormality of carpal bone ossification (HP:0006257) | 1.86726272 |
| 117 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86392439 |
| 118 | Abnormality of the costochondral junction (HP:0000919) | 1.84843251 |
| 119 | Multiple lipomas (HP:0001012) | 1.83669387 |
| 120 | Right ventricular cardiomyopathy (HP:0011663) | 1.82606788 |
| 121 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.82321532 |
| 122 | Glomerulosclerosis (HP:0000096) | 1.81933168 |
| 123 | Abnormal biliary tract morphology (HP:0012440) | 1.80957138 |
| 124 | Renal tubular dysfunction (HP:0000124) | 1.79908781 |
| 125 | Chondrocalcinosis (HP:0000934) | 1.76501420 |
| 126 | Enlarged kidneys (HP:0000105) | 1.76323400 |
| 127 | Metaphyseal irregularity (HP:0003025) | 1.76231125 |
| 128 | Potter facies (HP:0002009) | 1.74831978 |
| 129 | Facial shape deformation (HP:0011334) | 1.74831978 |
| 130 | Pili torti (HP:0003777) | 1.73880506 |
| 131 | Petechiae (HP:0000967) | 1.73375976 |
| 132 | Symptomatic seizures (HP:0011145) | 1.72471386 |
| 133 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.72160233 |
| 134 | Late onset (HP:0003584) | 1.71303440 |
| 135 | Abdominal distention (HP:0003270) | 1.70658093 |
| 136 | Irritability (HP:0000737) | 1.68949950 |
| 137 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.68759934 |
| 138 | Hypocalcemia (HP:0002901) | 1.68250199 |
| 139 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67458258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.74864117 |
| 2 | WNK4 | 7.33726792 |
| 3 | WNK3 | 6.32766231 |
| 4 | OXSR1 | 6.18575408 |
| 5 | FRK | 3.75598844 |
| 6 | MST1R | 3.65033411 |
| 7 | STK39 | 3.64521580 |
| 8 | MST4 | 3.24610415 |
| 9 | BCKDK | 2.11395399 |
| 10 | STK38L | 2.09983411 |
| 11 | PDK4 | 2.01984901 |
| 12 | PDK3 | 2.01984901 |
| 13 | LMTK2 | 2.00188314 |
| 14 | NEK1 | 1.81613808 |
| 15 | PDK2 | 1.63714615 |
| 16 | GRK6 | 1.61940677 |
| 17 | NME1 | 1.58981607 |
| 18 | MAP3K12 | 1.58973242 |
| 19 | MYLK | 1.50972715 |
| 20 | WNK1 | 1.50689446 |
| 21 | MAP2K2 | 1.46058208 |
| 22 | MAP3K2 | 1.44200023 |
| 23 | TYK2 | 1.42877328 |
| 24 | PIK3CA | 1.38918297 |
| 25 | EPHA3 | 1.30721685 |
| 26 | STK24 | 1.30342111 |
| 27 | TNIK | 1.29891271 |
| 28 | RIPK1 | 1.29588600 |
| 29 | PTK6 | 1.27714676 |
| 30 | SGK223 | 1.22069555 |
| 31 | SGK494 | 1.22069555 |
| 32 | MET | 1.21717587 |
| 33 | PRKG2 | 1.18420440 |
| 34 | MAP4K1 | 1.15992995 |
| 35 | EPHA4 | 1.14222895 |
| 36 | PRPF4B | 1.06567949 |
| 37 | LRRK2 | 1.02727322 |
| 38 | TESK1 | 0.93679488 |
| 39 | BMPR2 | 0.92958113 |
| 40 | PTK2 | 0.89072891 |
| 41 | MAP3K7 | 0.88205305 |
| 42 | EPHB1 | 0.87649988 |
| 43 | PAK4 | 0.87483670 |
| 44 | KSR2 | 0.86527202 |
| 45 | ERN1 | 0.83380595 |
| 46 | FGFR3 | 0.83149514 |
| 47 | PRKCI | 0.79830662 |
| 48 | STK38 | 0.79275209 |
| 49 | LATS1 | 0.76693368 |
| 50 | SGK3 | 0.75601067 |
| 51 | NLK | 0.75183637 |
| 52 | EPHB2 | 0.73859003 |
| 53 | AKT3 | 0.73256297 |
| 54 | STK10 | 0.71406670 |
| 55 | FER | 0.70884317 |
| 56 | MAPK11 | 0.69890392 |
| 57 | CDC42BPA | 0.68815255 |
| 58 | GSK3A | 0.68499209 |
| 59 | PRKAA1 | 0.67337894 |
| 60 | PRKAA2 | 0.66479433 |
| 61 | FGFR4 | 0.66416366 |
| 62 | MAP2K1 | 0.63592556 |
| 63 | EPHA2 | 0.57595904 |
| 64 | TTK | 0.56902997 |
| 65 | PAK3 | 0.56802020 |
| 66 | MAP3K3 | 0.56322384 |
| 67 | PDPK1 | 0.54602875 |
| 68 | SGK2 | 0.49354312 |
| 69 | IRAK1 | 0.48317735 |
| 70 | PINK1 | 0.48209598 |
| 71 | DYRK1B | 0.47655528 |
| 72 | CASK | 0.47010433 |
| 73 | YES1 | 0.45433592 |
| 74 | TBK1 | 0.43897203 |
| 75 | FYN | 0.41064455 |
| 76 | RET | 0.40610979 |
| 77 | ABL2 | 0.39835728 |
| 78 | MAP3K10 | 0.39274499 |
| 79 | TAOK1 | 0.38564530 |
| 80 | ERBB2 | 0.38478407 |
| 81 | JAK1 | 0.37144535 |
| 82 | CSF1R | 0.36658346 |
| 83 | ZAP70 | 0.36305524 |
| 84 | DDR2 | 0.35979054 |
| 85 | PDK1 | 0.35727233 |
| 86 | MAP3K8 | 0.35619480 |
| 87 | SYK | 0.34957644 |
| 88 | SGK1 | 0.34830952 |
| 89 | BTK | 0.34656521 |
| 90 | GRK1 | 0.33271343 |
| 91 | TEC | 0.32640499 |
| 92 | STK3 | 0.32513326 |
| 93 | CDK19 | 0.31784001 |
| 94 | NEK6 | 0.31492262 |
| 95 | STK11 | 0.30543404 |
| 96 | BMX | 0.30140474 |
| 97 | PDGFRA | 0.29569609 |
| 98 | IKBKE | 0.27483949 |
| 99 | MELK | 0.26740996 |
| 100 | CDK6 | 0.26155178 |
| 101 | PRKCZ | 0.25719127 |
| 102 | LYN | 0.25242003 |
| 103 | PRKCA | 0.24985473 |
| 104 | DAPK2 | 0.24735441 |
| 105 | ITK | 0.24472468 |
| 106 | PRKCD | 0.23577724 |
| 107 | LIMK1 | 0.22780571 |
| 108 | PRKACG | 0.22523221 |
| 109 | MAPKAPK2 | 0.22379663 |
| 110 | SCYL2 | 0.21718179 |
| 111 | ROCK1 | 0.20575228 |
| 112 | MATK | 0.20339718 |
| 113 | AKT2 | 0.19776781 |
| 114 | MAP3K14 | 0.19673545 |
| 115 | RPS6KA2 | 0.19057282 |
| 116 | PRKCQ | 0.18062645 |
| 117 | CAMK2G | 0.17920234 |
| 118 | IGF1R | 0.17516506 |
| 119 | LCK | 0.17354058 |
| 120 | INSRR | 0.17165831 |
| 121 | TRIB3 | 0.17153190 |
| 122 | PRKACA | 0.16778434 |
| 123 | CAMK2D | 0.16052159 |
| 124 | ERBB4 | 0.15736668 |
| 125 | NUAK1 | 0.14843457 |
| 126 | PIM1 | 0.14596355 |
| 127 | TESK2 | 0.14271616 |
| 128 | IRAK4 | 0.13842125 |
| 129 | TGFBR2 | 0.13265247 |
| 130 | MAP2K6 | 0.12615506 |
| 131 | SRC | 0.12272134 |
| 132 | MAP3K1 | 0.11679618 |
| 133 | NME2 | 0.11671858 |
| 134 | RIPK4 | 0.10863213 |
| 135 | MAP3K11 | 0.10440970 |
| 136 | CSNK1A1 | 0.10168001 |
| 137 | PTK2B | 0.10092060 |
| 138 | JAK2 | 0.08801212 |
| 139 | TIE1 | 0.08235633 |
| 140 | CAMK2B | 0.07574001 |
| 141 | CSK | 0.07203106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AMPK signaling pathway_Homo sapiens_hsa04152 | 4.98859238 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.40227140 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33182356 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.21747436 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.20641155 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.16125958 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.11627373 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.78552161 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.77597289 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67391266 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.58020121 |
| 12 | Mineral absorption_Homo sapiens_hsa04978 | 2.49858213 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 2.46835041 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.39310447 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.28289278 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24673858 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23163653 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.19000958 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12526243 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.03380207 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.99694224 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.92749713 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89588653 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.78277890 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77590916 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76565700 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.67292422 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.61660681 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58321214 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51278204 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.50715169 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48723527 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47240173 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45418896 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.42815124 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37674793 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36964927 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30282366 |
| 39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.26497997 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20055723 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.14822434 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11848435 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10610769 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.09214692 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07093660 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00549451 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99933698 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98066410 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95420900 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.94053211 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93047573 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90924099 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90553981 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.89500603 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88559046 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88111707 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85709113 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79664257 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74078981 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73807515 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72586012 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70785320 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69947401 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69395574 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.67757286 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66130229 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62497599 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61999391 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58833878 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55510598 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53584378 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49921605 |
| 73 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.47932341 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47702513 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47619581 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45470672 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43842524 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43025810 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41920489 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41423436 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40902720 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40827934 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.40707050 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.39915650 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39024316 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37100027 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36699418 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34263601 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.33924280 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33203202 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.31670249 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31391131 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29541795 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25060857 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24972364 |
| 96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24272449 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23736887 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.23445682 |
| 99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.23018885 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20620910 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19175768 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18338977 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17928206 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17539386 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16317556 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15574239 |
| 107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.15429329 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14856894 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.13777406 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.12992723 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12933369 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10542534 |
| 113 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.09814557 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.09613527 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.09485603 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.08957896 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.08286787 |
| 118 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.07522378 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06924756 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.06625170 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.06473510 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.05449343 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.05302183 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.04734942 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.02750690 |
| 126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.02748041 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.00478848 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.00282028 |
| 129 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.00157313 |

